Optimization of IV Ketamine in Treatment-Resistant Major Depression

ID Number 07-0114

Principal Investigator(s)
Dan V Iosifescu

Department(s) or Division(s)


The purpose of this study is to investigate the antidepressant mechanism of action of ketamine in patients with treatment-resistant major depression (TRD). We are looking for depressed participants suffering from Major Depressive disorder (MDD) who have not improved after several medication treatments for a research study with an investigational novel medication aiming to relieve symptoms of depression.  Participants would have up to two separate overnight stays at the Mount Sinai Hospital then follow-up visits in our clinic.  Eligible participants will receive treatment at no cost and compensation for their time.

Contact Information
Cara Levitch
(212) 241-3116

Recruiting Patients: No